A premier corporate governance and disclosure practice providing timely, tailored and practical advice to public company clients based on in-depth experience and insight.

Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.

Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

WilmerHale’s lawyers are renowned for their work on mergers and acquisitions, IPOs, private equity deals, strategic alliances and corporate governance matters both domestically and in the EU and China. Healthcare clients, which include Medtronic and PerkinElmer, know us as a one-stop source for solutions to the diverse array of corporate issues they face.

For clients that range from public and private companies to individual entrepreneurs, our corporate lawyers have:

• Served as issuer counsel or underwriters’ counsel in more than 400 public offerings and Rule 144A placements raising nearly $150 billion since 2006. We have a wide array of capital markets experience, as well as significant commercial finance knowledge.
• Advised on more than 1,000 M&A deals with a total value in excess of $400 billion since 2006. Our experience ranges from public-public mergers and related SEC, disclosure and fiduciary duty issues to the unique issues presented by sales of private equity and venture-backed private companies.
• Handled hundreds of strategic alliances, joint ventures, outsourcing and licensing transactions each year, including several strategic alliances that have received industry recognition for their importance. The complexity of these deals often demands deep experience and close collaboration among our corporate, licensing, intellectual property and tax lawyers, as well as our lawyers in the United States, Europe and Asia.

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.